Financial Disclosure

HomeAboutIndustry Resources ▶ Financial Disclosure
Financial Disclosure

ATS Compliance with the Council of Medical Specialty Societies
Code for Interactions with Companies

The American Thoracic Society (ATS) Board of Directors adopted the Council of Medical Specialty Societies Code for Interactions with Companies (CMSS Code) in October 2010.  The CMSS Code Standard 2.2 states:

“Societies will disclose Company support (at a minimum Educational Grants, Corporate
Sponsorships, Charitable Contributions, and support of Research Grants), making this
information available to their members and the public.”

In compliance with the CMSS Code, the ATS is pleased to disclose annually all financial and in-kind relationships with companies that support or participate in ATS activities, which helps make what we do possible. Below, please find disclosures for the period of January 1, 2018 to December 31, 2018. Companies are listed alphabetically by level.

Charitable contributions and educational grants in support of the ATS Foundation Research Program that are made to the ATS Foundation during 2018 are summarized on the Foundation’s website.


ATS 2018 Corporate Membership Program:


  • Actelion Pharmaceuticals US, Inc.; AstraZeneca LP; Bayer Healthcare; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech; Gilead Sciences, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Sanofi Genzyme and Regeneron Pharmaceuticals; Sunovion Pharmaceuticals, Inc.; Teva Respiratory; United Therapeutics Corporation


  • Boston Scientific Corporation; Insmed Incorporated; Mallinckrodt Pharmaceuticals; Mylan; PneumRx, Inc.; Vertex Pharmaceuticals, Inc.


  • Bellerophon Therapeutics; Santhera Pharmaceuticals Holding AG; Shionogi, Inc.


  • Bristol-Myers Squibb; Fisher & Paykel Healthcare; Pulmonx, Inc.; SomnoMed LTD.; Vitalograph Ltd.; Vivus, Inc.

Educational Grants (Accredited and Independent Non-Accredited Education):

$250,000 to $499,999:

  • None

$100,000 to $249,999:

  • Actelion Pharmaceuticals US, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc., Gilead Sciences, Inc.; GlaxoSmithKline; Vertex Pharmaceuticals, Inc.

$75,000 to $99,999:

  • AstraZeneca LP; Mallinckrodt Pharmaceuticals; Sunovion Pharmaceuticals, Inc.

$50,000 to $74,999:

  • Insmed Incorporated

$25,000 to $49,999:

  • Bayer Healthcare

$10,000 to $24,999:

  • Genentech; Olympus Corporation of the Americas; Sanofi Genzyme and Regeneron Pharmaceuticals

$1 to $9,999:

  • Boston Scientific Corporation

Collaborative Educational Programs:

$200,000 to $500,000:

  • Boehringer Ingelheim Pharmaceuticals, Inc.

$100,000 to $199,999:

  • None

$1 to $99,999:

  • GlaxoSmithKline

In Kind (Non-Monetary) Support (such as loan of equipment used in hands-on learning courses planned and controlled by the ATS):

  • Abbott Laboratories; Agilent Technologies; Ambu A/S; AstraZeneca Pharmaceuticals LP; BD; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific Corporation; Clement Clark International; Cook Medical; Edwards Lifesciences, Inc.; ERBE USA, Inc.; Fisher & Paykel Healthcare; FUJIFILM Medical Systems, USA, Inc.; FUJIFILM Sonosite, Inc.; GE Healthcare; Getinge AB; GlaxoSmithKline; Hill-Rom, Inc.; Medtronic; MicroDirect, Inc.; Mohaghan Medical; ndd Medical Technologies; Olympus Corporation of the Americas; Philips Respironics; ResMed; Smiths Medical; Sunovion Pharmaceuticals, Inc.; Teleflex Medical, Inc.; Teva Pharmaceuticals; Veran Medical Technologies; Verathon; Vyaire Medical

ATS Journal and Other Non-Conference Advertising:

$200,000 and above:

  • AstraZeneca Pharmaceuticals LP; GlaxoSmithKline; Sunovion Pharmaceuticals, Inc.

$50,000 to $200,000:

  • Allergan USA, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech; Gilead Sciences, Inc.; La Jolla Pharmaceutical Company; Sanofi Genzyme Regeneron

$35,000 to $49,999:

  • None

$15,000 to $34,999:

  • Actelion Pharmaceuticals US, Inc.; Boston Medical Products; Ganesco, Inc.; Insmed Incorporated; Northwestern Medicine; Temple University

$1 to $14,999:

  • Academy for Continued Health Care Learning; American Academy of Sleep Medicine; American Physician Institute; American Society of Microbiology; Bloomberg School of Public Health; Brigham & Women's Hospital; Bronson Healthcare Group; Children's Hospital of Pittsburgh; Cleveland Clinic; CSL; Eastern Pulmonary Conference; Fisher & Paykel Healthcare, Inc.; Grant Cooper; Grifols; Hamilton Medical, Inc.; Hologic; John Hopkins University; Kaiser Permanente; Mallinckrodt Pharmaceuticals; Massachusetts General Hospital; McFarland Clinic; MD Anderson Cancer Center; Med-IQ; Medtelligence; MetroHealth Medical Center; Mountain Medical Group; Mylan; National Jewish Health; Northwest Permanente; Novo Biomedical Corporation; Ohio State University Wexner; Roche Alecensa; Rochester Regional Health; Southern Illinois University School of Medicine; St. Joseph Health Care; Stanford Children's Health; Stanford University School of Medicine; Stemcell Technologies Canada Inc.; Tulane University School; University of Pittsburgh Department of Medicine; University of Pittsburgh Physicians; University of Pittsburgh; University of Rochester Medical Center; University of San Francisco; VA Palo Alto Health Care System; Veracyte; Vertex Pharmaceuticals, Inc.; WakeMed; Weill Cornell Medicine

ATS Journal Non-Advertising Revenue (Reprints)

$30,000 and above:

  • Actelion Pharmaceuticals US, Inc.; Wefra Media;

$15,000 to $29,999:

  • Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline

$1 to $15,000:

  • Cipla Limited; Content Ed Net; GEM/HME; Grifols; Havas Lynx; Idemm Farma; JNB McCann Health GmbH; Kazuma Nagata, et al.; MW Office; Novartis Pharmaceuticals Corporation; Orion Pharmaceuticals; Vertex Pharmaceuticals, Inc.; Roche Pharmaceuticals

Charitable Contributions:

  • No Disclosures

Exhibit, Industry Programs and International Conference Advertising Revenue:

$175,000 and above:

  • Genentech

$100,000 to $174,999:  

  • Actelion Pharmaceuticals US, Inc.; AstraZeneca LP; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Sanofi Genzyme Regeneron Pharmaceuticals

$50,000 to $99,999:

  • Gilead Sciences, Inc.; TEVA Respiratory; Vertex Pharmaceuticals

$20,000 to $49,999:  

  • Arena Pharmaceuticals; Biofire Diagnostics, Inc.; Boston Scientific Corporation; Medtronic (Covidien); NTM Info & Research, Inc.; Resmed Corp.; Sunovion Pharmaceuticals

$10,000 to $19,999:

  • 4Dx; Allergan USA, Inc.; Apnicure, Inc.; Bayer Healthcare; Biogen; Body Vision Medical; Broncus Medical; BTG; Fisher & Paykel Healthcare Inc.; Fujifilm Medical Systems; Grifols; Hill-Rom; Insmed Incorporated; Intuituve Surgical; Mallinckrodt Pharmaceuticals; MGC Diagnostics; Mylan Inc.; Nabriva Therapeutics; ndd Medical Technologies Inc; OncoCyte Corporation; Philips Respironics Inc.; Veran Medical Technologies; Vitalograph; Vyaire Medical

$1 to $9,999:

  • 3D Systems, Healthcare; 3M; Adherium Limited; Advance Vascular Models; Allegheny Health Network; Allergy and Asthma Network; Alpha-1 Foundation; Altus Infusion; AMBU; American Board of Internal Medicine; American College of Chest Physicians (CHEST); American College of Physicians; APSR 2018 Taipei; ARDS Foundation; Arena Pharmaceuticals, Inc.; Asian Pacific Society of Respirology; Asociacion Argentina de Medicina Respiratoria; Associates of Cape Cod, Inc.; Asthma and Allergy Foundation of America; Auris Health; B. Braun; Bat-A-Call;BD; Bedfont Scientific LTD; Bellerophon Therapeutics; Biodesix; Bristol-Myers Squibb; Bosch Healthcare Solutions GmbH; Boston Medical Products; Brazilian Thoracic Society; Breathe Technologies; Brigham & Women's Hospital, Inc; Bruker Corporation; Canadian Thoracic Society; Celgene Caring; Charles River Laboratories;  Cheetah Medical; CHI Mercy Medical Center; Children's Interstitial & Diffuse Lung Disease Foundation; Christus Health;  Cincinnati Children's Hospital; Circassia Pharmaceuticals; Clement Clarke International; CMI Health Inc.; Cohero Health; Contec Medical Systems CO, LTD; Cook Medical; Coreline Soft Ltd.; COSMED; CRC Press/Taylor Francis Group; Curetis USA; Cystic Fibrosis Research, Inc.; Data Sciences International; DKBmed; Eastern Pulmonary Conference; ECO Medics - ECO Physics; Egyptian Pediatric Pulmonary Society; e-LinkCare Meditech Co.,Ltd; Elsevier; ENDOCLEAR LLC; ERBE USA; eResearch Techology Inc. (ERT); European Respiratory Society; FDA Center for Tobacco Products; Fibrogen, Inc; FLUIDDA NV; Foundation for Sarcoidosis Research; FutureMed; Ganshorn LLC; Goldstein and Associates, Inc.; Great Lakes Orthodontics; Hans Rudolph, Inc.; HCA (Hospital Corporation of America);  HCMed Innovations; Hermansky Pudlak Syndrome Network, Inc.; IASLC; ID by DNA, Inc.; Imbio, LLC; Indian Chest Society; Infinity Massage Chairs; Innovative ECMO Concepts, Inc.; Innovus Pharmaceuticals; Inspire Medical Systems; International Biophysics; International Institute for the Advancement of Medicine; International Society for Aerosols In Medicine; Interpace Diagnostics; Irish Thoracic Society; Itamar Medical; Janssen Pharmaceuticals; Japanese Respiratory Society; Jazz Pharmaceuticals; Johns Hopkins Center for Global NCD Research and Training; Kaiser Permanente; Konica Minolta; Level-Ex; Lung Transplant Foundation; LUNGevity Foundation; Lymol Medical Corporation; Lymphangiomatosis & Gorham's Disease Alliance; Masimo; Maxor Specialty; Mayo Clinic; Med Systems; Medical Developments International (MDI); Medical Device Mentors; MedQIA; Mehow Innovative Ltd; Memorial Health System; Methepharm; Micro Direct, Inc.; MIR Medical International Research USA; Molekule; Monaghan Medical Corporation; Monitored Therapeutics; Morgan Scientific; Mount Sinai Health System; National Board for Respiratory Care; National Disease Research Interchange; National Heart Lung and Blood Institute; National Jewish Health; Nebraska Medicine/UNMC; Neilmed Pharmaceuticals; NeuWave Medical; Novabiosis; nspire Health; NTM Info & Research, Inc.; Open Source Imaging Consortium (OSIC); Optellum Ltd.; Owlstone Medical Ltd.; Oxynov; PAD A CHEEK LLC; PAH.TV; Pan African Thoracic Society (PATS); Passy Muir, Inc.; patientMpower Ltd.; PCD Foundation; Pediatric Search Partners; Penn State Health Milton S. Hershey Medical Center; PFM Medical; Phoenix Children's Hospital; Pinnacle Biologics; PracticeLink; Propeller Health; Providence St. Joseph Health; Public Health Foundation of India; Pulmonary Fibrosis Foundation; Pulmonary Hypertension Association; PulmOne USA Inc.; Pulmonx; Rabbit Air; RB (Reckitt Benckiser Pharmaceuticals); Reata Pharmaceuticals; Relapsing Polychondritis Awareness and Support Foundation, Inc.; Renown Health; Restor3d; Riverside Health System; Rocket Medical; Samsung (NeuroLogica Corp.); SCIREQ USA Inc.;Scleroderma Foundation; Shionogi Inc.; SomnoMed, Inc.; SOMNOmedics; Sonosite FujiFilm; Sound Critical Care; SoutheastHEALTH; Stemcell Technologies, Inc.; Temple Lung Center; The JAMA Network; The Lam Foundation; Thirona; Thoracent, Inc.; Thoracic Society of Australia and New Zealand; THORASYS; Trihealth; TSI Helathcare; Tuberous Sclerosis Alliance; Turkish Thoracic Society (TTS); U.S. Acute Care Solutions; US Environmental Protection Agency; U.S. Jaclean, Inc.; UF Health Shands Children's Hospital; UMPC; US Army Healthcare Team; US Army Medicine Civilian Corp; Veracyte; Vida Diagnostics; VitaLink; Vituity; Vivus; Wolters Kluwer Health

All questions about the Society’s interactions with industry should be directed to Michelle Turenne - Chief, Corporate Alliances and Business Development ( or 212-315-6448).